TABLE 4.
Classify | Natural products | Targets of research | Efficacy | References |
---|---|---|---|---|
Alkaloids | Neferine | collagen I and III 、 TGF-β1 | Restrain the migration of CFs | Zhao et al. (2010) |
TGF-β1-Smad、ERK、p38MAPK | Improving myocardial function in diabetic mice | Liu et al. (2016) | ||
Picrasidine | TGF-β1、Smad2/3 | Improving the cardiac compliance and cardiac function | Zhang et al. (2018b) | |
Terpenoids | Zerumbone | TGF-β1、p-Smad2/3、MMP-2/9、Smad7 | Inhibits the conversion of cardiac fibroblasts to myofibroblasts | Li et al. (2022c) |
Ginkgolide B | ERK1/2、JNK、38MAPK | Restraining the development of diabetic MF | Wu et al. (2013) | |
Jang et al. (2020) | ||||
Centella asiatica | Smad2/3、Smad7 | Alleviating the overburden pressure-induced cardiac fibrosis | Lu et al. (2018) | |
Betulinic acid | Smad2/3、TGF-β1 | Relieving the hyperglycaemia-induced cardiac fibrosis | Jiang et al. (2017) | |
Flavonoids | Daidzein | Smad2/3、TGF-β1 | Suppressing the development of cardiac disease | Yu et al. (2020) |
Apigenin | miR-122-5p、TGF-β1、Smad2/3、HIF-1α、Smad7 | Anti-fibrosis effect | Zhou et al. (2016) | |
Feng et al. (2021) | ||||
Glycyrrhizin | TGF-β1、Smad2 | Relieved fibrosis in mice and cardiomyocytes by suppressing | Li et al. (2021b) | |
Silymarin | TGF-β1、Smad2/3、Smad7 | Decreasing MF and collagen deposition | Meng et al. (2019) | |
Baicalin | TGF-β、Smad2/3、Smad4 | Anti-fibrosis effect | Xiao et al. (2018) | |
Saponins | Astragaloside IV | TGF-β1、Smad3、Smad7 | Anti-fibrosis effect | Wei et al. (2020) |
Saikosaponin A | smad2、smad3、smad4 | Attenuate the cardiac fibrosis and inhibiting the EndMT process | Fu et al. (2015) | |
Liu et al. (2018b) | ||||
Polyphenols | Resveratrol | TGF-β1、Smad2、Smad3 | Reducing ECM deposition and alleviating HG-induced cardiac fibrosis | Gambini et al. (2015) |
Zhu et al. (2022) | ||||
Others | Emodin | SMAD2/3、Erk1/2 | Anti-cardiac fibrosis | Carver et al. (2021) |
Higenamine | TGF-β1、Smad | Improving cardiac fibrosis and dysfunction | Zhu et al. (2021) |